HYFTOR vs LORBRENA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. HYFTOR and LORBRENA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	HYFTOR	LORBRENA
Rating	New	64/100
Pharmacy pays	~$48.61 /30	—
Type	RX	RX
Active ingredient	SIROLIMUS	LORLATINIB
Manufacturer	Nobelpharma	Pfizer
Dosage forms	Topical	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms	—

hyftor lorbrena

Rating

New

64/100

Pharmacy pays

~$48.61 /30

—

Type

Active ingredient

SIROLIMUS

LORLATINIB

Manufacturer

Nobelpharma

Pfizer

Dosage forms

Topical

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

—

Frequently asked questions

What is the difference between Hyftor and Lorbrena?

Hyftor contains Sirolimus, while Lorbrena contains Lorlatinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.